¼¼°èÀÇ ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀå
Medical Cyclotron
»óǰÄÚµå : 1769004
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀåÀº 2030³â±îÁö 5¾ï 8,130¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 3¾ï 1,830¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 10.6%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 5¾ï 8,130¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ 16-18 MeV´Â CAGR 10.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 3¾ï 1,780¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 10-12 MeV ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 10.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8,210¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 13.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀåÀº 2024³â¿¡ 8,210¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 13.9%·Î 2030³â±îÁö 1¾ï 3,320¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 7.1%¿Í 8.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 8.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ±â¼úÀº ¹æ»ç¼º ÀǾàǰÀ» ¾î¶»°Ô ÁøÈ­½Ãų °ÍÀΰ¡?

ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·ÐÀº ÀÔÀÚ °¡¼Ó±âÀÇ ÀÏÁ¾À¸·Î ÀÇ·á¿ë ¿µ»ó Áø´Ü ¹× ¾Ï Ä¡·á¿¡ »ç¿ëµÇ´Â ¹æ»ç¼ºµ¿À§¿ø¼Ò »ý»ê¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. »çÀÌŬ·ÎÆ®·ÐÀº ºÒ¼Ò18°ú °°Àº µ¿À§¿ø¼Ò¸¦ »ý¼ºÇÏ¿© ¾çÀüÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(PET) ½ºÄµ¿¡ »ç¿ëµË´Ï´Ù. ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·ÐÀ» »ç¿ëÇÏ¿© º´¿øÀ̳ª Áø´Ü¼¾ÅÍ¿¡¼­ ¹æ»ç¼ºµ¿À§¿ø¼Ò¸¦ ÇöÀå¿¡¼­ »ý»êÇÒ ¼ö ÀÖÀ¸¸ç, ¿ÜºÎ °ø±Þ¾÷ü¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß°í ¹Ý°¨±â°¡ ªÀº µ¿À§¿ø¼ÒÀÇ ¾ÈÁ¤ÀûÀÎ °ø±ÞÀ» º¸ÀåÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ¾Ï, ½ÉÀ庴, ½Å°æÁúȯ µîÀÇ Áúȯ¿¡ ´ëÇÑ Á¤¹ÐÇÑ ¿µ»ó Áø´Ü°ú Ç¥ÀûÄ¡·á°¡ °¡´ÉÇϹǷΠ¸ÂÃãÇü ÀǷḦ ÁøÇàÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¾î¶² Çõ½ÅÀÌ ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀåÀº µ¿À§¿ø¼ÒÀÇ »ý»ê È¿À²¼º°ú ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â ±â¼ú Çõ½ÅÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¼ÒÇü »çÀÌŬ·ÎÆ®·Ð ¼³°èÀÇ ¹ßÀüÀ¸·Î ¼Ò±Ô¸ð ÀÇ·á½Ã¼³¿¡¼­µµ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾î PET ½ºÄµÀÇ º¸±ÞÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ »õ·Î¿î Ç¥Àû ¹°Áú°ú °³¼±µÈ µ¿À§¿ø¼Ò ȸ¼ö ±â¼úÀº ¹æ»ç¼ºµ¿À§¿ø¼Ò ¼öÀ²À» Çâ»ó½ÃŰ°í Æó±â¹°À» ÁÙÀÌ¸ç º´¿ø ºñ¿ëÀ» Àý°¨Çϰí ÀÖ½À´Ï´Ù. µ¿À§¿ø¼Ò Á¦Á¶ ÈÄ ¹æ»ç¼º ÀǾàǰÀ» Á÷Á¢ Á¦Á¶ÇÏ´Â ÀÚµ¿ ÇÕ¼º ½Ã½ºÅÛ°úÀÇ ÅëÇÕµµ ÁÖ¿äÇÑ ¹ßÀüÀ¸·Î, ¹«±Õ¼ºÀ» º¸ÀåÇϰí Á¦Á¶ °úÁ¤¿¡¼­ ÀÎÀû ¿À·ù¸¦ ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº »çÀÌŬ·ÎÆ®·Ð ±â¼úÀ» º¸´Ù Àú·ÅÇÏ°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô Çϰí, µ¿½Ã¿¡ ¿µ»ó Áø´Ü ¹× Ä¡·áÀÇ ÁúÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·ÐÀÇ ¼ºÀåÀ» ¾î¶»°Ô Á¤ÀÇÇϴ°¡?

Á¦Ç° À¯Çü¿¡´Â °í¿¡³ÊÁö »çÀÌŬ·ÎÆ®·Ð°ú Àú¿¡³ÊÁö »çÀÌŬ·ÎÆ®·ÐÀÌ ÀÖÀ¸¸ç, Àú¿¡³ÊÁö Àåºñ´Â ºñ¿ë È¿À²¼º°ú ºÒ¼Ò 18°ú °°Àº ÀϹÝÀûÀÎ µ¿À§¿ø¼Ò¸¦ »ý¼ºÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ °¡Àå ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. ¿ëµµ´Â ¿µ»ó Áø´Ü ¹× Ä¡·á ¿ëµµ¿¡ °ÉÃÄ ÀÖÀ¸¸ç, PET ¿µ»ó Áø´ÜÀÌ Á¾¾çÇÐ ¹× ½Å°æÇп¡¼­ Áß¿äÇÑ Åø·Î ³²¾Æ ÀÖÀ¸¹Ç·Î °¡Àå Å« ºÎ¹®ÀÔ´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í PET ½ºÄµÀÇ ³ôÀº º¸±Þ·ü·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖÀ¸¸ç, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ È®´ëµÇ¸é¼­ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·Ð ½ÃÀåÀÇ ¼ºÀåÀº ¿µ»ó Áø´Ü ¼ö¿ä Áõ°¡, ¾Ï ¹× ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ ¿äÀο¡ ±âÀÎÇϸç, PET ¿µ»óÀÌ ´Ù¾çÇÑ Áúº´ÀÇ Áø´Ü ¹× ¸ð´ÏÅ͸µ¿¡ ³Î¸® »ç¿ëµÊ¿¡ µû¶ó »çÀÌŬ·ÎÆ®·Ð¿¡¼­ »ý»êµÇ´Â ¹æ»ç¼ºµ¿À§¿ø¼Ò¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹æ»ç¼ºµ¿À§¿ø¼Ò¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¿À§¿ø¼Ò¸¦ Á÷Á¢ ¾Ï Ä¡·á¿¡ »ç¿ëÇϴ ǥÀû ¹æ»ç¼± Ä¡·áÀÇ ¹ßÀüÀ¸·Î ÀÇ·á¿ë »çÀÌŬ·ÎÆ®·ÐÀÇ Ä¡·á ¿ëµµ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚµµ ÷´Ü Áø´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ô¿© ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(16-18 MeV, 10-12 MeV, 19-24 MeV, 24 MeV & Above)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

°ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇÕ´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Cyclotron Market to Reach US$581.3 Million by 2030

The global market for Medical Cyclotron estimated at US$318.3 Million in the year 2024, is expected to reach US$581.3 Million by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. 16-18 MeV, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$317.8 Million by the end of the analysis period. Growth in the 10-12 MeV segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$82.1 Million While China is Forecast to Grow at 13.9% CAGR

The Medical Cyclotron market in the U.S. is estimated at US$82.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$133.2 Million by the year 2030 trailing a CAGR of 13.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Medical Cyclotron Market - Key Trends and Drivers Summarized

How Is Medical Cyclotron Technology Advancing Radiopharmaceuticals?

A medical cyclotron is a type of particle accelerator that plays a crucial role in the production of radioisotopes used in medical imaging and cancer treatment. Cyclotrons generate isotopes like Fluorine-18, which are used in positron emission tomography (PET) scans, a diagnostic tool that helps detect diseases at their earliest stages. The ability to produce radioisotopes on-site in hospitals and diagnostic centers using medical cyclotrons reduces reliance on external suppliers and ensures a stable supply of isotopes with short half-lives. This technology is critical for advancing personalized medicine, as it enables precise imaging and targeted treatments for conditions like cancer, heart disease, and neurological disorders.

What Innovations Are Shaping the Medical Cyclotron Market?

The medical cyclotron market is benefiting from innovations that improve isotope production efficiency and safety. Advances in compact cyclotron design are making these devices more accessible to smaller healthcare facilities, allowing more widespread use of PET scans. Additionally, new target materials and improved isotope recovery techniques are enhancing the yield of radioisotopes, reducing waste and lowering costs for hospitals. Integration with automated synthesis systems that prepare radiopharmaceuticals directly after isotope production is another key development, ensuring sterility and minimizing human error in the preparation process. These innovations are making cyclotron technology more affordable and accessible while improving the quality of diagnostic imaging and treatment.

How Do Market Segments Define the Growth of Medical Cyclotrons?

Product types include high-energy and low-energy cyclotrons, with low-energy devices being the most widely adopted due to their cost-effectiveness and ability to produce common isotopes like Fluorine-18. Applications span across diagnostic imaging and therapeutic uses, with PET imaging being the largest segment as it remains a key tool in oncology and neurology. Geographically, North America leads the market due to its advanced healthcare infrastructure and high adoption of PET scans, while Asia-Pacific is experiencing growth as investment in healthcare technology expands across the region.

What Factors Are Driving the Growth in the Medical Cyclotron Market?

The growth in the medical cyclotron market is driven by several factors, including the increasing demand for diagnostic imaging, the rising prevalence of cancer and chronic diseases, and the growing focus on personalized medicine. As PET imaging becomes more widely used in diagnosing and monitoring various diseases, the demand for cyclotron-produced radioisotopes is rising. Additionally, advancements in targeted radiotherapy, which uses isotopes for direct cancer treatment, are expanding the therapeutic applications of medical cyclotrons. Government investments in healthcare infrastructure, particularly in emerging markets, are also contributing to market growth by increasing access to advanced diagnostic technologies.

SCOPE OF STUDY:

The report analyzes the Medical Cyclotron market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (16-18 MeV, 10-12 MeV, 19-24 MeV, 24 MeV & Above)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â